This has been already provided many posts ago, I invited you to have a look at it, it contains all the evidences you are asking for, all data, researches and whatever you might wish for from the most prominent authority about BPC 157 research, obviously you didn't care to check it out as usual.
https://www.google.c...4142764A1?cl=en
Well, since you aren't going to make the effort to click the link AS USUAL, I'll do for you and copy and paste the relevant parts here:
Numerous pharmacological studies have demonstrated a protective, regenerative and therapeutical activity of pentadecapeptide (abbr. BPC-157 or bepecin) having an amino acid sequence: Gly Glu Pro Pro Pro Gly Lys Pro Ala Asp Asp Ala Gly Leu Val (SEQ ID NO 1) to both a human and animal organism. Until now, this peptide has always been used either in a free form or in an acetate form or as a salt with bases such as sodium salt. All these forms have been characterized by still not adequate stability in gastric juice, which particularly limits oral use of these compounds and simultaneously decreases their therapeutic value. It has therefore been necessary to manufacture this pentadecapeptide in a form which is substantially more stable both in gastric juice and at raised ambient temperature. Such form of the preparation could be used more successfully particularly in oral delivery into an organism. Due to higher stability an overall better effectiveness would be expected as well
The fundamental problem to be solved is stability of the compound at an increased temperature, in particular the stability in gastric juice. The present invention relates to novel pentadecapeptide salts with basic amino acids having Significantly improved thermal stability and also stability in gastric juice.
The stability of bepecin di-L-arginine salt (1 : 2, abbr. Arg-BPC) at an increased temperature was determined by an accelerated ageing method at 50 °C and relative humidity of 65 %, which represents relatively very stringent conditions for a compound having a peptide structure.
Table 1. Pentadecapeptide content decrement in standing at 50 °C and relat. humidity 65 %:
Substance: 0 day 10 davs 30 davs 60 davs 90 davs
BPC acetate 99.65 % 95.97 % 91.98 % 85.49 % 85.90 %
BPC Na salt 99.20 % 97.22 % 96,46 % 97.38 % 97.14 %
Are-BPC 99.46 % 99.29 % 99.20 % 98.96 % 99.07 %
Arg- 99.46 % 99.37 % 99.29 % 99.16 % 99.15 %
BPC/NaHCO,
Lvs-BPC 99.47 % 99.24 % 99.27 % 98.90 % 99.28 % The table further shows that the addition of sodium hydrogen carbonate to bepecin salt increases its stability at an increased temperature
The stability of bepecin salt with L-arginine in water solutions was determined after incubation of aqueous salt solutions in concentration 1 g/ 100 ml, at 50 °C, and in a separate test in very stringent conditions: at 100 °C, where the decomposition was determined after one hour.
Table 2. Pentadecapeptide content decrement in water at 50 °C / time (hours):
Substance: pH start/0 20 65 148 388
BPC acetate 3.88 98.89 % 71.17 % 55.25 % 52.55 % ' 21.30 %
BPC Na-salt 8.42 99.01 % 98.36 % 97.47 % N.D. 96.74 %
Arg-BPC 7.35 99.05 % 98.97 % 99.04 % 99.10 % 99.01 %
Lys-BPC 7.28 99.07 % 99.40 % 99.09 % 99.35 % 99.01 %
Orn-BPC 7.12 100.00 % 99.64 % 99.78 % 99.59 % 99.44 %
Table 3. Pentadecapeptide content decrement in water at 100 °C - 1 hour:
Substance: start after 1 hour
BPC acetate 98.89 % 56.80 %
BPC Na-salt 99.01 % 98.56 %
Arg-BPC 99.05 % 99.08 % (unchanged!)
Stability of a compound in gastric juice is an important parameter, particularly in peptides, which very rapidly decompose in the presence of pepsine enzyme and in an acidic medium. Better stability in gastric juice means a longer period, in which the compound is available for resorption and its therapeutical activity. Artificial gastric juice illustrates the conditions in normal human gastric juice and contains: 0.08 mol of hydrochloric acid, 0.03 mol of sodium chloride and 1.0 g of pepsin in 1000 ml of water.
The studied peptide salt in concentration 10 mg/5 ml was incubated in artificial gastric juice with pH values 2.0, 3.0 and 4.0 at 37 °C.
Table 4. Pentadecapeptide content decrement (rel. %) in gastric juice at pH = 2.0
Substance: Time (hours):
0 0.5 1.0 1.5 2.0 2.5
BPC acetate 100 21.4 8.2 4.75 2.46 2.1
BPC Na-salt 100 21.6 6.7 4.4 4.2 2.7
Arg-BPC 100 30.2 13.5 8.2 6.0 4.9
Table 5. Pentadecapeptide content decrement (rel. %) in gastric juice at pH = 3.0
Substance: Time (hours):
0 0.5 1.0 2.0 3.0 4.0 5.0
BPC acetate 100 41.7 26.1 7.8 2.5 1.1 0.08
BPC Na-salt 100 81.9 71.6 56.0 40.2 29.7 10.1
Arg-BPC 100 98.1 96.5 93.6 90.0 87.2 84.9
Table 6. Pentadecapeptide content decrement (rel. %) in gastric juice at pH = 4.0
Substance: Time (hours):
0 1 2 3 4 5 6 7 8
BPC acetate 100 89.7 81.3 72.5 60.9 56.4 48.8 44.6 38.0
BPC Na-salt 100 99.0 98.9 94.6 89.7 78.3 76.3 68.2 60.9
Arg-BPC 100 99.9 99.5 98.7 96.1 89.8 84.6 73.5 67.2 The content of pentadecapeptide BPC-157 in tested samples was determined by HPLC method in the following system:
column: Reprosil Orpegen CI 8, 100, 5 μιτι, 250 * 4.6 mm,
mob. phase A: 0.1 % trifluoroacetic acid/5 % acetonitrile/water
mob. phase B: 0.1 1 % trifluoroacetic acid/40 % acetonitrile/water
gradient: from 100 % A to 30 % A in 25 min
temperature: 20 °C
flow: 1.5 ml/min
detection: UV, 210 nm
The results of stability determination show that bepecin salts with basic amino acids are substantially more stable than other hitherto known salts of pentadecapeptide in question, which is surprisingly a huge advantage. In any case these new salts are better than bepecin salts with different amines, alkali and earth alkali metals according to patents EP 0983300 and US No. 6,288,028, which are prone to formation of polar degradation product (up to 10 %, structure not yet defined). A consequence of better stability is also better biological activity, since the intact compound is present in an organism for a longer period of time and available for more efficient resorption.
Stability in Light
Compounds of such type are very susceptible to ultraviolet light. An aqueous solution of Arg-BPC (1 g/100 ml of water) at 20 °C was radiated with ultraviolet light of a wavelength of 253.7 nm and absorption was measured within wavelength range from 230 to 350 nm over a period of 70 min every 10 min. The results are represented in Fig. 1 and confirm that the compound is stable.
Now keep claiming there is no evidence if you dare.
The fact that you don't check the evidence I provide doesn't make me not providing any as you keep claiming, you are the one whom NEVER provided any to support your ideas.
Prove me wrong, common, I am here waiting.
And by the way the above isn't MY BELIEF, you are the one relying ONLY on YOUR OWN BELIEF ignoring whatsoever evidence not matching your wishes.